About Careers MedBlog Contact us

BP Drug Limits Lung Disease

by Sheela Philomena on December 20, 2011 at 2:12 PM
Font : A-A+

 BP Drug Limits Lung Disease

Lostartan - a drug widely used to treat high blood pressure reduces cigarette smoke-induced lung disease in mice, shows study.

The discovery by Enid Neptune and colleagues, at Johns Hopkins University, Baltimore, provides hope for the development of therapies for chronic obstructive pulmonary disease (COPD).


COPD is among the most common causes of death in the US. It is a smoking-related disease for which there are currently no disease-altering therapies.

Losartan blocks the protein angiotensin receptor type 1, and its effects on cigarette smoke-induced lung injury were a result of the fact that blocking angiotensin receptor type 1 leads to a decrease in levels of the soluble molecule TGF-beta.

The authors therefore suggested that other TGF-beta-targeted therapeutics might also be viable candidates for the treatment of COPD.

Source: ANI

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

BP Drug Limits Lung Disease Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests